PUBLICATIONS

  1. Yang HW, Wu YH, Lin MC, Liao SF, Fan CC, Wu CS, Wang S-H* (2023/08 online): Association between neighborhood availability of physical activity facilities and cognitive performance in older adults. Preventive Medicine. (IF=4.637, Medicine, General & Internal, 56/172, 33%)
  2. Chen YL, Liao WH, Wang S-H, Lien YJ, Chang CM, Liao SC, Huang WL, Wu CS* (2023/06 online): Changes in employment status and income before and after newly diagnosed depressive disorders in Taiwan: a matched cohort study using controlled interrupted time series analysis. Epidemiology and Psychiatric Sciences. (IF=7.818, Psychiatry, 18/142, 13%)
  3. Lane HY, Wang S-H, Lin CH* (2023/06 online): Differential Relationships of NMDAR Hypofunction and Oxidative Stress With Cognitive Decline. Psychiatry Research. (IF=11.225, PSYCHIATRY, 16/155, 10%)
  4. Chiu YW, Su MH, Lin YF, Chen CY, Chen TT, Wang S-H* (2023/07 online): Causal influence of sleeping phenotypes on the risk of coronary artery disease and sudden cardiac arrest: a Mendelian randomization analysis. Sleep Health. (IF=4.207, Clinical Neurology, 87/212, 41%)
  5. Yang CW, Lin MC, Shu KH, Tung KT, Tsai WC,…Wang S-H*, Pan SY* (2023/05): Extremely low Dose of erythropoiesis-stimulating agent may be associated with increased mortality in hemodialysis patients. American Journal of Nephrology 54 (1-2): 25–34.
  6. Chen YL, Tseng CH, Cheong ML, Lien YJ, Wang S-H, Chang CM, Liao SC, Wu CS* (2023/04): Associations between antenatal education program and mental health outcomes in Taiwan: A population-based cohort study. Psychiatry Research 322: 115128. (IF=11.225, Psychiatry, 15/157, 10%)
  7. Lane HY, Wang S-H, Lin CH* (2023/02): Endogenous Antioxidants Predicted Outcome and Increased after Treatment: a Benzoate Dose-finding, Randomized, Double-blind, Placebo-controlled Trial for Alzheimer's Disease. Psychiatry and Clinical Neurosciences 77(2): 102-109. (IF=12.145, Clinical Neurology, 10/212, 5%)
  8. Liao SF, Su CY, Su MH, Chen CY, Chen CY, Lin YF, Pan YJ, Hsiao PC, Chen PC, Huang YT, Wu CS, Wang S-H* (2023/01): Associations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank. Journal of Affective Disorders 320: 397-403. (IF=6.533, Clinical Neurology, 29/212, 14%)
  9. Wang S-H*, Wu CS, Hsu LY, Lin MC, Chen PC, Wesley KT, Fan CC (2022/12): Paternal age and 13 psychiatric disorders in the offspring: A population-based cohort study of 7 million children in Taiwan. Molecular Psychiatry 27(12): 5244-5254. (IF=13.437, neurosciences, 13/274, 5%)
  10. Su MH, Lai RY, Lin YF, Chen CY, Feng YCA, Hsiao PC, Wang S-H* (2022/09): Evaluation of the causal relationship between smoking and schizophrenia in East Asia. npj Schizophrenia 8(1): 72. (IF=4.966, Psychiatry, 59/155, 38%)
  11. Lin CH, Wang S-H, Lane HY* (2022/08): Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: A randomized, double-blind, sertraline- and placebo-controlled trial. International Journal of Neuropsychopharmacology 12: pyac006. (IF=5.678, Clinical Neurology, 42/212, 20%)
  12. Wang S-H, Su MH, Chen CY, Lin YF, Feng YCA, Hsiao PC, Pan YJ, Wu CS* (2022/05): Causality of abdominal obesity on cognition: a trans-ethnic Mendelian randomization study. International Journal of Obesity 46: 1487–1492. (IF= 5.551, endocrinology & metabolism, 39/146, 27%)
  13. Su MH, Shih YH, Lin YF, Chen PC, Chen CY, Hsiao PC, Pan YJ, Liu YL, Tsai SJ, Kuo PH, Wu CS, Huang YT, Wang S-H* (2022/05): Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes. Diabetologia 65(5): 800-810. (IF=10.460, endocrinology & metabolism, 11/146, 8%)
  14. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S,…Wang S-H,… O’Donovan MC*, Schizophrenia Working Group of the Psychiatric Genomics Consortium (2022/04): Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604: 502–508. (IF= 69.504, Multidisciplinary sciences, 1/134, 1%)
  15. Lu YC, Chen PT, Lin MC, Lin CC, Wang S-H*, Pang YJ* (2021/11): Nonsteroidal anti-inflammatory drugs reduce second cancer risk in patients with breast cancer: A nationwide population-based propensity score-matched cohort study in Taiwan. Frontiers in Oncology 11: 756143 (IF=5.738, oncology, 78/245, 32%)
  16. Wu CS, Hsu LY, Pan YJ, Wang S-H* (2021/11): Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 106(12): e5136-e5146. (doi: 10.1210/clinem/dgab443) (IF=6.134, endocrinology & metabolism, 32/146, 22%)
  17. Luo YC, Hsieh YC, Wu JW, Quyen TLT, Chen YY, Liao WC, Li SW, Wang S-H, Pan YJ* (2021/10): Exploring the association between capsular types, sequence types, and carbapenemase genes in Acinetobacter baumannii. International Journal of Antimicrobial Agents 59(1): 106470. (IF=15.441, infectious diseases, 11/94, 12%)
  18. Wang S-H, Huang SP, Pan YJ, Hsiao PC, Li CY, Chen LC, Yu CC, Huang CY, Lin VC, Lu TL, Bao BY* (2021/05): Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancer. American Journal of Cancer Research 11(5): 2331-2342. (IF=5.942, oncology, 71/245, 29%)
  19. Lin CH, Chen PK, Wang SH, Lane HY* (2021/04): Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open 4(4): e216156. (IF=13.366, medicine, general & internal, 15/172, 9%)
  20. Lu YC, Huang DW, Chen PT, Tsai CF, Lin MC, Lin CC, Wang S-H*, Pang YJ* (2021/02): Association between statin use and second cancer risk in breast cancer patients: A nationwide population-based cohort study. Breast Cancer Research and Treatment 185(3): 773-783. (IF=4.642, oncology, 110/245, 45%)
  21. Hsieh YC, Wang S-H,Chen YY, Lin TL, Shie SS, Huang CT, Lee CH, Chen YC, Quyen TLT, Pang YJ* (2020/12): Association of Capsular Types with Carbapenem Resistance, Disease Severity and Mortality in Acinetobacter baumannii. Emerging Microbes & Infections 9: 2094-2104. (IF=19.568, infectious diseases, 8/94, 9%)
  22. Wang S-H*, Lai RY, Lee YC, Su MH, Chen CY, Hsiao PC, Yang AC, Liu YL, Tsai SJ, Kuo PH* (2020/06): Association between polygenic liability for schizophrenia and substance involvement: A nationwide population-based study in Taiwan. Genes, Brain and Behavior 19(5): e12639. (doi:10.1111/gbb.12639) (IF=3.708, Behavioral Science, 14/53, 26%)
  23. Chiu YW, Wu CS, Chen PC, Wei YC, Hsu LY, Wang S-H* (2020/03): Risk of acute mesenteric ischemia in patients with diabetes: a population-based cohort study in Taiwan. Atherosclerosis 296: 18-24. (IF=6.847, Peripheral vascular disease, 11/67, 16%)
  24. Lin CH, Yang HT, Chen PK, Wang S-H, Lane HY* (2020/02): Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD). Neuropsychiatric Disease and Treatment 16: 509–518. (IF=2.989, Psychiatry, 107/155, 69%)
  25. Wu CS, Hsu LY, Wang S-H* (2020/01): Association of depression and diabetes complications and mortality: a population-based cohort study. Epidemiology and Psychiatric Sciences 29: e96. (IF=7.818, Psychiatry, 18/142, 13%)
  26. Howrigan DP*, Rose SA., Samocha KE, Fromer M, Cerrato F, Chen WJ, Churchhouse C, Chambert K, Chandler SD, Daly MJ, Dumont A, Genovese G, Hwu H-G, Laird N, Kosmicki JA, Moran JL, Roe C, Singh T, Wang S-H, Faraone SV, Glatt SJ, McCarroll SA, Tsuang M, Neale BM* (2020/01): Schizophrenia risk conferred by protein-coding de novo mutations. Nature Neuroscience 23: 185-193. (doi:10.1038/s41593-019-0564-3) (IF=28.771, Neuroscience, 2/274, 1%)
  27. Wu CS, Kuo C-J, Su C-H, Wang S-H, Dai H-J* (2020/01): Using text mining to extract depressive symptoms and to validate the diagnosis of major depressive disorder from electronic health records. Journal of Affective Disorders 260: 617-623. (IF=6.533, Clinical Neurology, 29/212, 14%)
  28. Lin CH, Chen PK, Wang S-H, Lane HY* (2019/08): Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial. Journal of Psychopharmacology 33: 1030-1033. (IF=4.562, Pharmacology & Pharmacy, 102/274, 37%)
  29. Wang S-H, Hsiao PC, Yeh LL, Liu CM, Liu CC, Hwang TJ, Hsieh MH, Chien YL, Lin YT, Huang Y-T, Chen C-Y, Chandler SD, Faraone SV, Neale B, Glatt SJ, Tsuang MT, Hwu HG, Chen WJ* (2019/07): Advanced paternal age and early-onset of schizophrenia in sporadic cases: not confounded by parental polygenic risk to schizophrenia. Biological Psychiatry 86: 56–64. (IF=12.810, Psychiatry, 12/155, 7%)
  30. Wang S-H, Chen WJ, Hsu LY, Chien KL, Wu CS* (2018/11): Use of spontaneous reporting systems to detect host-medication interactions: Sex differences in oral anti-diabetic drug-associated myocardial infarction. Journal of the American Heart Association 7: e008959. (IF=6.106, Cardiac & Cardiovascular Systems, 42/143, 29%)
  31. Wang S-H, Hsiao PC, Yeh LL, Liu CM, Liu CC, Hwang TJ, Hsieh MH, Chien YL, Lin YT, Chandler SD, Faraone SV, Laird N, Neale B, McCarroll SA, Glatt SJ, Tsuang MT, Hwu HG, Chen WJ* (2018/01): Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia. Genes, Brain and Behavior 17: 49-55. (doi:10.1111/gbb.12401). (IF=3.708, Behavioral Science, 14/53, 26%)
  32. Woolston AL, Hsiao PC, Kuo PH, Wang S-H, Lien YJ, Liu CM, Hwu HG, Lu TP, Chuang EY, Chang LC, Chen CH, Wu JY, Chen WJ* (2017/07): Genetic loci associated with an earlier age at onset in multiplex schizophrenia. Scientific Reports 7: 6486.(doi:10.1038/s41598-017-06795-8) (IF=4.996, Multidisciplinary sciences, 19/73, 26%)
  33. Tsai C-Y, Wang S-H, Hsu M-H, Li Y-C* (2016/08): Do false positive alerts in naïve clinical decision support system lead to false adoption by physicians? A randomized controlled trial. Computer Methods and Programs in Biomedicine 132: 83-91. (IF=7.027, Computer Science, Theory & Methods, 12/109, 11%)
  34. Wang S-H, Ding Y, Zhao W, Huang Y-H, Perkins R, Zou W, Chen JJ* (2016/03): Text mining for identifying topics in the literatures about adolescent substance use and depression. BMC Public Health 16: 279. (IF=4.135, Public, Environmental & Occupational Health, 83/210, 40%)
  35. Wang S-H, Liu C-M, Hwu H-G, Hsiao CK, Chen WJ* (2015/07): Association of older paternal age with earlier onset among co-affected schizophrenia sib-pairs. Psychological Medicine 45: 2205-2213. (doi:10.1017/S0033291715000203) (IF=10.592, Psychology, Clinical, 5/130, 4%)
  36. Wang S-H, Lin I-C, Chen C-Y, Chen D-R, Chan T-C, Chen WJ* (2013/12): Availability of convenience stores and adolescent alcohol use in Taiwan: a multilevel analysis of national surveys. Addiction 108: 2081-2088. (doi:10.1111/add.12278) (IF=7.256, Substance Abuse, 2/21, 10%)
  37. Wang S-H, Chen WJ, Tsai Y-C, Huang Y-H, Hwu H-G, Hsiao CK*(2013/09): A stochastic inference of de novo CNV detection and association test in multiplex schizophrenia families. Frontiers in Genetics 4: 185. (doi: 10.3389/fgene.2013.00185) (IF=4.772, Genetics & Heredity, 43/175, 25%)
  38. Wang S-H, Chen WJ, Chuang L-M, Hsiao P-C, Liu P-H, Hsiao CK* (2013/02): Inference of cross-level interaction between genes and contextual factors in a matched case-control metabolic syndrome study: a Bayesian approach. PLoS ONE 8(2): e56693. (doi:10.1371/journal.pone.0056693) (IF=3.752, Multidisciplinary sciences, 29/73, 40%)
  39. Wang S-H, Hsiao P-C, Hsiao CK, Liu P-H, Chien K-L, Lin S-R, Lee W-C, Chen WJ* (2011/08): Multilevel analysis of habitual physical activity and metabolic syndrome in northern Taiwan. Preventive Medicine 53: 34-38. (doi:10.1016/j.ypmed.2011.04.017) (IF=4.637, Medicine, General & Internal, 56/172, 33%)
  40. Wang S-H, Chen W-C, Lew-Ting C-Y, Chen C-Y, Chen WJ* (2010/01): Running away experience and psychoactive substance use among adolescents in Taiwan: multi-city street outreach survey. BMC Public Health 10: 29-37. (IF=4.135, Public, Environmental & Occupational Health, 83/210, 40%)
Free Web Hosting